Hepatitis B Vaccination and First Central Nervous System Demyelinating Event: A Case-Control Study

Publisher： Karger

E-ISSN： 1423-0208|21|4|180-186

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.21, Iss.4, 2002-06, pp. : 180-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dietary and Alcohol Intake and Central Nervous System Tumors in Adults: Results of the CERENAT Multicenter Case-Control Study

By  

Neuroepidemiology, Vol. 47, Iss. 3-4, 2016-11 ,pp. : 145-154

Karger

Access to resources Recommend Favorite

Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: A case-control study

By Hatzakis A.   Katsoulidou A.   Kaklamani E.   Touloumi G.   Koumantaki Y.   Tassopoulos N.   Karvountzis G.   Gioustozi A.   Hadziyannis S.   Trichopoulos D.  

International Hepatology Communications, Vol. 7, Iss. 1, 1997-05 ,pp. : 66-66

Elsevier

Access to resources Recommend Favorite

Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases

By  

Current Immunology Reviews, Vol. 11, Iss. 2, 2015-08 ,pp. : 85-92

Bentham Science Publishers

Access to resources Recommend Favorite

Central nervous system biogenic amine targets for control of appetite and energy expenditure

By Nelson David   Gehlert Donald  

Endocrine Journal, Vol. 29, Iss. 1, 2006-02 ,pp. : 49-60

Humana Press, Inc

Access to resources Recommend Favorite

Regeneration in the central nervous system

By Bandtlow C.E.  

Experimental Gerontology, Vol. 38, Iss. 1, 2003-01 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite